Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Do Not Crush List
    • New Drugs
    • Original Container Meds
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Gliptins

Gliptins

  • Diabetes (599)
    • Blood Glucose Meters (7)
    • Complications (108)
    • Diabetes in Pregnancy (4)
    • Diabetes Meds (73)
    • Drug-Induced Hypo/Hyperglycemia (99)
    • Monitoring (86)
    • Natural Medicines/Supplements (11)
    • Prevention (26)
    • Treatment (217)
      • Alpha-Glucosidase Inhibitors (21)
      • Amylin Agonist (10)
      • Bromocriptine (4)
      • Combination Products (17)
      • Gliptins (63)
      • Glitazones (72)
      • GLP-1 (31)
      • Incretin Enhancers/Mimetics (46)
      • Insulin (128)
      • Meglitinides (32)
      • Metformin (94)
      • SGLT2 Inhibitors (56)
      • Sulfonylureas (80)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (10)
  • Hyperglycemia (25)
  • Hypoglycemia (23)
  • Other (21)
  • Prediabetes (2)
  • Resources (132)
  • Thyroid Disorders (51)
16 - 30 of 63 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
FAQ: Type 2 Diabetes in Children September 2021
Chart: Managing Diabetes Meds When Fasting September 2021
Patient Education: How to Handle Low Blood Sugar November 2019
Article: Know Which Diabetes Meds Help or Worsen Heart Failure March 2019
Technician Tutorial: Diabetes 101 March 2019
Chart: Stepwise Treatment of Type 2 Diabetes (Canada) June 2018
Chart: Comparison of Blood Glucose Meters February 2018
Chart: Lancets and Lancing Devices February 2018
Chart: Lancets and Lancet Devices February 2018
Algorithm: Stepwise Treatment of Hypertension (Canada)

June 2017
Article: Be Aware Glyxambi Combines Jardiance and Trajenta in One Tablet April 2017
Algorithm: Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes March 2017
Article: Avoid Mix-Ups With Trajenta, Trulicity, and Toujeo December 2016
Algorithm: Management of New-Onset Type 2 Diabetes October 2016
Chart: Canadian Cardiovascular Society Dyslipidemia Recommendations October 2016
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved